PRO-MSACTIVE Baseline Patient Characteristics: A Phase IV Study Evaluating Ocrelizumab in Active Relapsing Multiple Sclerosis

Affiliation auteurs!!!! Error affiliation !!!!
TitrePRO-MSACTIVE Baseline Patient Characteristics: A Phase IV Study Evaluating Ocrelizumab in Active Relapsing Multiple Sclerosis
Type de publicationJournal Article
Year of Publication2020
AuteursLaplaud D., Lebrun-Frenay C., Vukusic S., Moreau T., Grouin J.-M, Lotz M., Manchon E.
JournalEUROPEAN JOURNAL OF NEUROLOGY
Volume27
Pagination928
Date PublishedMAY
Type of ArticleMeeting Abstract
ISSN1351-5101